Lincoln Pharmaceuticals Ltd on Monday said its standalone revenues in the first quarter of 2013-14, ended June 30, increased 30 per cent compared to the corresponding quarter last fiscal.
Announcing its unaudited financial results, the revenues were Rs 39.23 crore (Rs 30.22 crore) while PAT stood at Rs 3.50 crore (Rs 1.12 crore).
The company increased its profitability in spite of the pressure of inflation, increase in input cost and financial cost in general economic conditions, according to a statement here.